[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics at the Center of Innovation ⑦ | BAZ BIOMEDIC Opens European Doors with 'Needle-Free Injection'
BAZ BIOMEDIC's needle-free micro-jet injection system 'CureJet' drew significant attention at IMCAS World Congress 2026. CureJet's core competitive edge is summed up in three words: 'Easy, Fast, and Shallow.' By precisely targeting the dermal layer—an area traditionally difficult to reach without skilled manual injection—CureJet enhances the delivery efficiency of skin boosters while offering a new approach to scar and stretch mark treatment. With over 400 units installed in Korea, the company has secured pan-European distribution contracts ahead of anticipated CE MDR certification in March, accelerating its global expansion. At this year's IMCAS, BAZ BIOMEDIC opted for three lecture sessions over a large exhibition booth, placing the clinical value of its technology front and center.
#MedicalAestheticNews #IMCAS2026 #BAZBIOMEDIC #CureJet #KMedicalAesthetics
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11202

Comments
Post a Comment